LRRC15 and non-small cell lung carcinoma: Using recent single-cell data consisting of human perturbation-specific activated fibroblast states76, we found that CAF-FAP partly overlapped with LRRC15+ CAFs from PDAC and NSCLC patients, indicating a cross-cancer prevalence.